All manuscript labeled with author(s) name and Title of the manuscript, should send by email to email address of Medical Association of Zenica-Doboj Canton: email@example.com All submitted manuscript gets its own number (ID) and authors informed about it and manuscript receiving. The ID number will be used in all future correspondence
Instructions for authors
Medical Association of the Zenica-Doboj Canton
Editiorial Office, Medicinski Glasnik
Zenica, 72000, Bulevar kralja Tvrtka I br. 4, Bosnia and Herzegovina
Phone: +387 (0) 32 44 42 70;
Fax: +387 (0) 32 44 42 71;
Medicinski Glasnik (pISSN 1840-0132, eISSN 1840-2445) is a peer-reviewed open access journal.
Med Glas (Zenica) is the acceptable title abbreviation. It is the official organ of and published by
the Medical Association of Zenica-Doboj Canton, Bosnia & Herzegovina. Evidence-based original
research papers, reviews, case studies, and opinion pieces of interest to medical specialists from
Bosnia & Herzegovina and other Balkan and Mediterranean countries are prioritized. The journal
reflects on progress in general and clinical medical sciences.
Editors of Medicinski Glasnik will do their best to process all submissions as early as
possible and publish accepted and edited items E-pub ahead of print. Full-text articles will be
freely available to readers immediately upon online publication.
Medicinski Glasnik follows the updated recommendations of the International Committee of
Medical Journal Editors (ICMJE) (http://icmje.org/icmje-recommendations.pdf) and adheres to
publication ethics standards set by the Committee on Publication Ethics
(COPE; http://publicationethics.org/resources) and the Council of Science Editors
To properly report different types of research studies, authors are advised to consult
the statements of the EQUATOR network at: http://www.equator-network.org/
Finally, editors of Medicinski Glasnik endorse the principles of the integrity, transparency and
quality of pre- and post-publication communications set by the Sarajevo Declaration on Integrity
and Visibility of Scholarly Publications (http://www.cmj.hr/2016/57/6/28051276.htm).
Aims and scope
The Editor-in-Chief and other staff members of the journal are in the position to provide
editorial assistance for preparation, submission substantive editing and publication of
manuscripts within the scope of the journal’s interests. We are committed to educate our authors
from non-mainstream science countries and improve their writing and professional information
We prioritize methodologically and scientifically sound original research that may influence
progress in the regional medicine. Overviews and opinion pieces shedding the light on
general medical issues in transitional and developing countries are welcome.
Medicinski Glasnik levies an article-processing charge for every accepted article to cover the
editing and publishing costs. The article-processing charge is 250 EURO (except for the
members of the Medical Association Zenica-Doboj Canton, B&H). Additionally, pages
containing color figures will be charged with 102.30 Euro per page.
All submissions are checked by the Editor-in-Chief, other staff members and by at least 2
external reviewers prior to a publication decision. Resposibilities and rights of our editors are in
accordance with the editorial policies set by the World Association of Medical Editors
All manuscripts are considered to be confidential.
Editor-in-Chief reads every manuscript received and assigns it a general priority level: a)
manuscript is sent to reviewers immediately (double-blind peer review); b) manuscript is
returned to authors with suggestions for modification and improvement; c) rejected
manuscripts. The Editor-in-Chief reads the revised manuscript. Authors are welcome to suggest
up to five potential reviewers for their manuscript, excluding co-authors or collaborators for the
last three years, or to ask for the exclusion of reviewer(s) and provide reasons for it. The Editor-
in-Chief's decision is final.
Our review process from submission to first decision takes approximately six weeks.
Each published item receives a DOI (Digital Object Identifier) which is unique for every
article published in the journal and is used for easier referencing and archiving.
Plagiarism detection and retractions
Editors check all accepted manuscripts for texts and graphics plagiarism. In some cases, authors
may be asked to provide a disclaimer that their reports are free of any research misconduct. In
all suspected cases, the editors act in accordance with the COPE flowcharts:
Plagiarized or otherwise unethical and erroneous published items will be retracted in
accordance with the COPE retraction
All manuscript labeled with author(s) name and title of the manuscript should be send by
email to the email address of Medical Association of Zenica-Doboj Canton at
firstname.lastname@example.org Every submitted manuscript gets its own number (ID) and
authors informed about it and manuscript receiving. The ID number will be used in all future
The Author Submission Statement (signed by all authors separately) should be and sent us
by e-mail along with the Conflict of Interest statement (see Conflict of Interest section).
Anyone listed as an author should meet all 4 criteria of authorship proposed by the
1) Substantial contributions to conception and design, acquisition of data, or analysis
and interpretation of data;
2) Drafting the article or revising it critically for important intellectual content;
3) Final approval of the version to be published; and
4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately investigated and resolved.
Individuals who simply provide technical assistance, e. g. supplied facilities, strains or reagents
or who critiqued the paper should not be listed as authors, but can be listed in the
The corresponding author has the authority to act on behalf of all other authors in all matters
pertaining to publication of the manuscript.
All authors are advised to provide their updated ORCID IDs which can be freely obtained at:
The corresponding author is responsible for obtaining permission from both the original
author and the original publisher (i.e. the copyright owner) to reproduce or modify figures and
tables and to reproduce text (in whole or in part) from previous publications.
The original signed permission(s) must be submitted directly to the editor and should be
identified as a relevant item in the MG manuscript (e.g. “permissions for Fig. 1 in MG-02-
08/04”). In addition, a statement indicating that the material is being reprinted with a
permission must be included in the relevant figure legend or table footnote of the manuscript.
Conflicts of interest
All authors, reviewers and editors are responsible for disclosure of any financial and non-
financial conflicts of interest that may compromise the trustworthiness of their reports. It
is therefore recommended to familiarize with the ICMJE statements and fill related
conflicts disclosure form: http://icmje.org/conflicts-of-interest/ and send us by e-mail
along with Authorship Statement.
Research ethics considerations
Any clinical and experimental research reported in the manuscript should be performed with the
approval of an appropriate ethics committee, and it should be stated in the Material and Methods
section. Research carried out on humans must be in compliance with the Helsinki Declaration,
and any experimental research on animals must follow internationally recognized guidelines. A
statement of this effect must appear in the Methods section of the manuscript, including
the name of the body which gave approval, with reference number where appropriate.
Informed consent must also be documented. Manuscripts may be rejected if the editorial
office considers that the research has not been carried out within an ethical framework, e.g. if
the severity of the experimental procedure is not justified by the value of the knowledge gained.
To protect the privacy of individuals mentioned in clinical studies, in case histories, do not
identify them by their names or initials, do not give hospital unit numbers. For all articles that
include information or clinical photographs relating to individual patients, a written and signed
consent from each patient to be published must also be mailed or faxed to the editorial staff.
The manuscript should also include a statement to this effect in the Acknowledgements section,
as follows: ”Written consent was obtained from the patient or their relative for publication of
Editorial: 1000 words maximum; up to 20 references; unstructured abstract up to 100 words (if
Review: 5000 words maximum; comprehensive references; 3-5 key words; unstructured
abstract up to 250 words.
Original article: 5000 words maximum; comprehensive references; 3-5 key words; structured
abstract up to 250 words.
Case Report which constitutes the entire article (Case report category) will not be published, but
only case report as a part of an original article. The Case Report section, placed after the
Introduction and before Materials and Methods, giving relevant clinical information about one
or more patients while being incidental to the rest of the paper.
Erratum: provides means of correcting errors that occurred during writing, typing, editing, or printing. Send directly to: Medical Chamber of Zenica-Doboj Canton, Editorial Office, Medicinski Glasnik, Bulevar kralja Tvrtka I br. 4, 72000, Zenica, Bosna i Hercegovina.
Organization of the Manuscript
Manuscripts can be submitted in English (with UK spelling).
Manuscript should be double-spaced (up to 30 lines per page) with 2.5 cm of each side margin.
All pages should be numbered, including the Title page.
Brevity is an advantage. Do not repeat text in more than one section; do not include text that is
redundant with tables and figures. SI units should be used whenever appropriate. Genus and
species names should be written in italic in full on first mention. The genus name should then be
abbreviated on subsequent mention provided that no ambiguity will arise. Only generic names
of drugs should be used, although trade names may follow in parentheses if necessary for
comprehension. Suppliers of specific instruments or compounds should be noted in parentheses,
providing both the company name and location.
All manuscripts should have the Title page (separate page), Abstract (separate page), Main Text,
Acknowledgements, Funding, Transparency declaration, References, list of tables and figures,
tables and figures.
All submissions in all categories must include a title page (on separate page) indicating the
intended category, the title, the full names and institutional affiliations of each author. The title
should give an indication of the scope of the study, but should not be a statement of the
conclusions. Please include a running title of up to 40 characters (with spaces). A
corresponding author must be named, including a complete postal address, international
telephone and fax numbers and e-mail address.
The second page should contain the Abstract, no more than 250 words, with 3-5 key words. In
selecting key words the author should strictly refer to the Medical Subject Headings (MeSH)
list of the Index Medicus. It should not be descriptive, but should contain only important facts
raised from the manuscript. Structured Abstract only for Original article: Aim of the study,
Methods, Results (main, with numbered data), Conclusion (basic).
Introduction represents a short description of the problem described in the manuscript and
purpose of the study. There is a need to mention only the references in direct relationship with
a problem presented in the manuscript. Continue logically and finish the section with a short
description of the aim of the study.
Material/Patients and Methods should present concisely and systematically a list of basic
procedures, selection of study subjects or laboratory animals, methods of observations and
analysis. Avoid listing common or irrelevant methods (use reference instead). The essential
data on patient characteristics belong here, not in the result section.
Results section should represent a list your basic results without any introduction. Only
essential statistical significances should be added in brackets. Draw no conclusions as yet: they
belong into the next section.
Discussion includes interpretation of study findings and results considered in the context of
results in other trials reported in the literature. Conclusions should be stated in a short, clear and
simple manner, stemming directly from the results shown in the paper. Rather than
summarizing the data, conclude from them.
Tables, figures and illustrations
Illustrations should be kept to a minimum. Data reported in tables or figures should not
be repeated in the text.
Each table (figure, illustration) should be presented on a separate page in the smaller format
possible and contain: a) descriptive or explanatory title; b) respective number (using Arabic,
not roman numerals) consecutively as cited in the text; c) all the necessary explanations of
symbols and abbreviations
Wherever possible tables should be typed as text using ‘tabs’ to align columns. The use of
table’s editors should be avoided, as should graphics software to create tables. Please do not use
paragraph returns within tables to indicate spacing within blocks of text; use instead a soft return
(shift return). Abbreviations may be used, but must be explained in full as footnotes. Units of
measurement must be clearly indicated.
Hard copy of all figures (MS Excel, cdr, eps files) must be prepared and retained by authors
in case it is needed during the publication process.
Illustrations must be delivered in high-quality electronic format, labeled with the number and
author name. To protect privacy of individuals, the eyes must be covered with black colour on
the patient's pictures.
Abbreviations and jargon are discouraged, but SI units should be abbreviated throughout.
Other abbreviations should be used only if mentioned three or more times in the text, and
should always be written in full on first mention. This applies separately to the Abstract and the
rest of the text.
All results presented previously at a scientific meeting or in another public context must
be acknowledged, giving the context, location and date of presentation.
Acknowledged individuals must be named in full.
All articles must include ”Funding” section. This section should appear after the
”Acknowledgement” section. Authors must list any source of funds, i.e. details of funding
of work, or authors, or professional help in writing a work, as follows: ”This work was
supported…..”, including full official funding agency name and reference number.
If no specific funding has been received than this also should be clearly stated: ”Funding:
no specific funding was received for this study”
All authors must disclose any degree of commercial or potential dual interest, financial and
personal relationships with other people or organizations that could inappropriately influence
(bias) their work (employment, consultancies, stock ownership, honoraria, paid expert
testimony, patent applications/registrations, and grants or other in this section.
If there is no any conflict, it should be stated: ”Conflicts of interest: Nothing to declare”.
Each scientific fact and publicized statement in the text requires a relevant reference.
Preferably, references should be widely visible on the Internet and refer to the most recent
sources. Citing retracted and ‘predatory’ items is unacceptable.
The author is responsible for the accuracy and completeness of all references, which should be
numbered sequentially and not alphabetically, with the numbers cited in the text in
parenthesis, before punctuation marks, according to the Vancouver style (examples
following). Provide names of all authors. Consult List of Journals in Index Medicus for
standard journal abbreviations.
Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CI. Multiplexed
biochemical assays with biological chips. Nature 1993; 364:555-6.
The Royal Marsden Hospital Bone-Marow Transplantation Team. Failure of syngeneic bone-
marrow graft without preconditioning in posthepatitis marrow aplasia. Lancet 1977; 2:242-4.
Anonymous. Coffee drinking and cancer of the pancreas (Editorial). Br Med J 1981; 283:628.
Lundstrom E, Nylander C. An electrostatic approach to membranes bound receptors. Period Biol
1983; 85(suppl 2):53-60.
Whole book (personal authors)
Berry MJ, Linoff G. Data mining techniques for marketing, sales and customer support. New
York: Wiley, 1997.
Whole book (editors)
Finch RG, Greenwood D, Norrby SR, Whitley RJ, eds. Antibiotic and chemotherapy. 8th ed.
Philadelphia: Churchill Livingston, 2003.
Weinstein L, Swartz MN. Pathogenic properties of invanding microorganisms. In: Sodeman
WA, ed. Pathogenic physiology: mechanism of disease. Philadelphia: W B Saunders, 1974:457-
Published meeting abstract
Uzunovic-Kamberovic S, Zorman T, Hendrickx M, Smole-Mozina S. Epidemiological
relatedness among C. jejuni and C. coli PFGE genotypes from different sources. In: Abstracts of
the 11th International Congress of Infectious Diseases, Cancun, Mexico, 2004. Abstract
P59.003, p. 188. International Society of Infectious Diseases, Boston, MA, USA.
Hunninghake GW, Gadek JE, Szapiel SV. The human alveolar macrophage, In: Harris CC, ed.
Cultured human cells and tissues in biomedical research. New York: Academic Press, 1980: 54-
6. (Stoner GD, ed. Methods and respective in cell biology; vol. 1)
Publication of agenses, societies
Ranofsky AI. Surgical operations in short-stay hospitals: United States – 1975, Hyattsville,
Marylend: National Centre for Health Statistics, 1978; DHEW publication no (PHS) 78-1785.
(Vital and health statistics; series 13; no 34)
Ph. D. or MA theses
Cairins RR. Infrared spectroscopic studies of solid oxygen. Berkley, University of
California, Los Angeles 1965; Ph. D. thesis.
World Health Organization. Global strategy for the containment of antimicrobial resistance.
http://www.who.International (date last accessed; an example: 07 July 2011).
Dimick JB, Welch hg, Birkmeyer JD. Surgical mortality as an indicator of hospital
quality. JAMA 292. [Online] posting or revision date. http://jama.ama-
assn.org/cgi/content/short/292/7/847. (date last accessed, an example: 07 July 2011)
References to (personal) unpublished data should be made parenthetically in the text (an
example: Brankovic, unpublished data).
Copyright transfer agreement will be sent to the corresponding author when a manuscript
is accepted and scheduled for publication. Unless this agreement is executed (signed) the
manuscript will not be published.
Page proofs (as a PDF, portable document format) will be sent to the Corresponding Author by
an e-mail, and should be returned within three days of receipt to the Secretary of MG.
Significant textual alterations are unacceptable at proof stage and authors will be responsible for
the cost of changes other than corrections of typesetting errors.
This will enable the file to be opened, read on screen and printed out in order for any
corrections to be added. Further instructions will be sent with the proof. Hard copy proofs will
be posted or faxed if no e-mail address is available. If we do not receive corrections in 3
business days, we will assume that we have your approval for publications.
Author material archive policy
Please note that unless specifically requested, we will dispose of all submitted hardcopy or
electronic material one year after publication. If you require the return of any submitted
material, please inform the editorial office or production editor as soon as possible if you have
not yet done so.
We will supply each author (or corresponding author, where the group of authors submitted)
with one copy of the MG.